Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
National Institute on Drug Abuse (NIDA) |
---|---|
Information provided by: | National Institute on Drug Abuse (NIDA) |
ClinicalTrials.gov Identifier: | NCT00040066 |
The purpose of this study is to assess the development of human laboratory study model of cocaine relapse prevention.
Condition | Intervention | Phase |
---|---|---|
Cocaine-Related Disorders |
Procedure: Cocaine (IV) |
Phase I |
Study Type: | Interventional |
Study Design: | Treatment, Double-Blind, Placebo Control, Parallel Assignment |
Official Title: | Development of Human Laboratory Study Model of Cocaine Relapse Prevention |
Estimated Enrollment: | 32 |
Study Start Date: | May 2002 |
Estimated Study Completion Date: | August 2003 |
The primary objective of this study will be to develop experimental procedures and parameters demonstrating arousal and craving responses to cocaine-related environmental cues as a model for future testing of the relapse prevention medication treatment of cocaine addiction.
Ages Eligible for Study: | 18 Years to 55 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Please contact site directly for details.
United States, California | |
UCLA Integrated Substance Abuse Program | |
Los Angeles, California, United States, 90024 | |
United States, Texas | |
University of Texas Health Science Center | |
San Antonio, Texas, United States, 78284 |
Principal Investigator: | John Roache, Ph.D. | National Institute on Drug Abuse (NIDA) |
Study ID Numbers: | NIDA-CTO-0013-1 |
Study First Received: | June 18, 2002 |
Last Updated: | October 23, 2007 |
ClinicalTrials.gov Identifier: | NCT00040066 |
Health Authority: | United States: Food and Drug Administration |
Cocaine-Related Disorders Dopamine Mental Disorders |
Substance-Related Disorders Disorders of Environmental Origin Cocaine |
Dopamine Uptake Inhibitors Neurotransmitter Agents Neurotransmitter Uptake Inhibitors Molecular Mechanisms of Pharmacological Action Physiological Effects of Drugs Anesthetics Central Nervous System Depressants Cardiovascular Agents |
Pharmacologic Actions Anesthetics, Local Sensory System Agents Therapeutic Uses Vasoconstrictor Agents Dopamine Agents Peripheral Nervous System Agents Central Nervous System Agents |